Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -290,976 | -230,699 | -119,491 | -79,049 | -57,221 |
| Depreciation Amortization | 5,740 | 1,847 | 1,688 | 2,965 | 3,513 |
| Accounts payable and accrued liabilities | 4,213 | -1,958 | 2,163 | 981 | 1,005 |
| Other Working Capital | -4,148 | 15,003 | 7,201 | -725 | 6,186 |
| Other Operating Activity | 49,545 | 36,035 | 20,937 | 15,803 | 9,361 |
| Operating Cash Flow | $-235,626 | $-179,772 | $-87,502 | $-60,025 | $-37,156 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 66,031 | -160,364 | 120,141 | 86,761 | -219,643 |
| PPE Investments | -5,572 | -35,925 | -20,232 | -3,020 | -290 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -194 |
| Investing Cash Flow | $60,459 | $-196,289 | $99,909 | $83,741 | $-220,127 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -486 | -528 | N/A | N/A | N/A |
| Common Stock Issued | 195,967 | 365,567 | 20,405 | 600 | 263,873 |
| Other Financing Activity | -6,695 | -7,503 | -357 | -94 | -4,647 |
| Financing Cash Flow | $188,786 | $357,536 | $20,048 | $506 | $259,226 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -94 |
| Beginning Cash Position | 62,092 | 80,617 | 48,162 | 23,940 | 21,897 |
| End Cash Position | 75,711 | 62,092 | 80,617 | 48,162 | 23,746 |
| Net Cash Flow | $13,619 | $-18,525 | $32,455 | $24,222 | $1,849 |
| Free Cash Flow | |||||
| Operating Cash Flow | -235,626 | -179,772 | -87,502 | -60,025 | -37,156 |
| Capital Expenditure | -5,733 | -35,925 | -20,232 | -3,020 | -290 |
| Free Cash Flow | -241,359 | -215,697 | -107,734 | -63,045 | -37,446 |